Our group develops and optimizes specialized genomics assays used in cancer research and diagnosis. Here are the lists of specialized assays we offer as services to CCR investigators:
Liquid Biopsy Assays
In the rapidly evolving field of oncology, liquid biopsy assays play a crucial role in the detection and characterization of tumors.
- cfDNA/ctDNA extraction and QC from plasma and other biofluid
- cfDNA/ctDNA based rare tumor mutation detection assay
- cfDNA/ctDNA based methylation assay for tumor signature detection
- cfDNA fragmentomics analysis
- cfDNA/ctDNA custom designed assays
Immunotherapy Related Assays
Explore advanced immunotherapy-related assays that enhance our understanding of receptor dynamics and behavior.
- TCR sequencing based on DNA
- TCR sequencing based on RNA
- Vector integration site analysis for CART and TCRT clonality analysis or clonal expansion analysis
CRISPR Cas9 sgRNA Library Screening
These innovative sequencing assays play a crucial role in advancing our understanding of cancer biology
- Wide collection of multiplex primers for most sgRNA libraries
- Special primers to deal with low diversity sequencing issues
Cancer Detection Assays
Discover key assays that are essential for advancing immunotherapy research.
- WES for FFPE or cancer samples with limited input
- Targeted and high sensitivity assay for specific genes
DNA Assays
Our cutting-edge DNA analysis combines industry-leading platforms to deliver comprehensive extraction and interpretation.
- Bisulfite sequencing
- EMseq on gDNA or cfDNA
- Biomodal 5mC and 5hmC on gDNA or cfDNA
- Targeted DNA methylation for specific CpGs or Genes
- DNA mutation and methylation Duo assay
RNA Assay & Gene Expression
Our RNA assay and gene expression services leverage the power of leading technologies to deliver precise, scalable, and actionable transcriptomic insights .
- Takara RNA based TCRseq
- Low-cost global gene expression
